0001171843-26-003440
SEC filingWestport Fuel Systems reported a 69% decline in consolidated Q1 2026 revenue to $2.3 million, driven by the expiration of its Heavy-Duty OEM transitional service agreement with Cespira, while Cespira’s revenue rose 33% and High-Pressure Controls revenue grew 21%, though the company disclosed substantial doubt about its ability to continue as a going concern given projected cash insufficiency over the next twelve months.
Westport’s Q1 2026 results reflect a deliberate strategic pivot: the Heavy-Duty OEM segment exited its transitional service agreement with Cespira at end-Q2 2025, eliminating $5.0 million in prior-year revenue and driving the consolidated 69% YoY revenue decline. This structural shift underscores Westport’s transition from direct OEM services to a more asset-light, equity-partnership model centered on Cespira — whose standalone revenue surged 33% to $22.2 million, fueled by 48% higher product sales ($19.5M) tied to LNG HPDI truck deployments across Europe and a second-OEM trial. Meanwhile, the High-Pressure Controls segment delivered 21% revenue growth to $2.3 million, anchored in engineering service revenue for OEM product testing — signaling traction in North American CNG storage commercialization following ACT Expo visibility. Despite these positive segment trends, consolidated profitability deteriorated: gross profit collapsed 66% YoY to $0.5 million, and net loss from continuing operations widened modestly to $5.7 million, while Adjusted EBITDA turned deeply negative ($4.9M) due to gross margin compression and absence of discontinued operations’ $2.8 million prior-year profit. Critically, liquidity concerns dominate the outlook: with $24.5 million cash and $1.9 million debt as of March 31, 2026, management explicitly states that cash is insufficient to fund operations for the next twelve months under current plans — triggering a formal going-concern qualification. Though Westport reduced Cespira funding to $2.9 million (from $4.7M) and highlights progress in scaling its China Hydrogen Innovation Center and Ontario facility, near-term viability hinges entirely on execution of unconfirmed financing alternatives — including public market raises or new debt — with no assurances of success. Investor focus must therefore center on liquidity risk mitigation and Cespira’s ability to convert growing product revenue into sustainable, self-funding scale.